Searchable abstracts of presentations at key conferences in endocrinology

ea0029p816 | Endocrine tumours and neoplasia | ICEECE2012

Anti-proliferative effect of GHRH antagonist JMR-132 on ovarian cancer cell via EGFR-Akt pathway

Guo J. , Schally A. , Leung P.

Antagonists of growth hormone-releasing hormone (GHRH) are being developed for the treatment of various human cancers. In this study, we investigated the effectiveness of GHRH antagonist JMR-132 treatment in ovarian cancer cell lines (SKOV-3, CaOV-3 and OVCAR-3). Using MTT assay, we found that JMR-132 has a strong anti-proliferation effects on SKOV-3 and CaOV-3 cells in a time (0, 24 h, 48 h, 72 h, 96 h) and dose (0, 25 nM, 50 nM, 100 nM and 200 nM) dependent manner. Also, JMR...

ea0029p1181 | Obesity | ICEECE2012

Metformin in normoglycemic obesity: a systematic review

Li S. , Guo J. , Lv X. , Liu Y. , Chen T. , Tian H.

Objective: Metformin was considered as a weight lowering agent in diabetes patients, while it remained unclear in simple obesity patients. We aimed to investigate if metformin is effective and safe in the therapy of normoglycemic obesity.Methods: We systematically searched MEDLINE (1950–2011), EMBase (1950–2011), and CCTR (4th Issue 2011), and collected and screened all randomized controlled trials compared metformin and placebo in obese partic...